However, the emergence of new SARS-CoV-2 variants as Omicron which evade immunity because of multiple mutations in the spike protein raises concerns about the efficacy of these Ig products against COVID-19 in patients with antibody deficiencies. The gene discussed is CHMP5; the disease is COVID-19.